Healthcare provider profile · identity verified

Lora Kim Meadows, MD

Internal Medicine · HILTON HEAD, SC · NPI 1255391496

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	416	103
Atorvastatin Calcium	Atorvastatin Calcium	384	109
Rosuvastatin Calcium	Rosuvastatin Calcium	271	79
Losartan Potassium	Losartan Potassium	225	67
Zolpidem Tartrate	Zolpidem Tartrate	175	33
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	170	54
Ezetimibe	Ezetimibe	165	44
Azithromycin	Azithromycin	161	104
Eliquis	Apixaban	157	29
Alprazolam	Alprazolam	153	48
Amlodipine Besylate	Amlodipine Besylate	132	38
Metoprolol Succinate	Metoprolol Succinate	128	45
Valsartan	Valsartan	125	39
Omeprazole	Omeprazole	124	42
Mounjaro	Tirzepatide	104	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	103	34
Paroxetine Hcl	Paroxetine Hcl	101	24
Pravastatin Sodium	Pravastatin Sodium	101	30
Alendronate Sodium	Alendronate Sodium	98	33
Famotidine	Famotidine	82	28
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	82	49
Gabapentin	Gabapentin	80	28
Lisinopril	Lisinopril	78	26
Escitalopram Oxalate	Escitalopram Oxalate	77	20
Doxycycline Hyclate	Doxycycline Hyclate	74	53
Methylprednisolone	Methylprednisolone	74	58
Sertraline Hcl	Sertraline Hcl	74	23
Myrbetriq	Mirabegron	66	15
Estradiol	Estradiol	64	18
Paxlovid	Nirmatrelvir/Ritonavir	63	61
Lorazepam	Lorazepam	56	15
Potassium Chloride	Potassium Chloride	56	17
Doxepin Hcl	Doxepin Hcl	55	16
Meloxicam	Meloxicam	55	24
Ondansetron Odt	Ondansetron	55	38
Tramadol Hcl	Tramadol Hcl	55	19
Repatha Sureclick	Evolocumab	53	suppressed
Fluticasone Propionate	Fluticasone Propionate	52	14
Topiramate	Topiramate	51	16
Clonazepam	Clonazepam	49	suppressed
Simvastatin	Simvastatin	49	14
Synthroid	Levothyroxine Sodium	47	14
Valacyclovir	Valacyclovir Hcl	47	22
Hydrochlorothiazide	Hydrochlorothiazide	46	14
Celecoxib	Celecoxib	42	13
Albuterol Sulfate Hfa	Albuterol Sulfate	40	18
Citalopram Hbr	Citalopram Hydrobromide	40	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	40	26
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	14
Pregabalin	Pregabalin	38	suppressed
Bupropion Xl	Bupropion Hcl	37	14
Diazepam	Diazepam	37	12
Furosemide	Furosemide	37	15
Metformin Hcl Er	Metformin Hcl	36	13
Tamsulosin Hcl	Tamsulosin Hcl	35	suppressed
Glimepiride	Glimepiride	34	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	33	32
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	26
Olmesartan Medoxomil	Olmesartan Medoxomil	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	31	suppressed
Ozempic	Semaglutide	30	suppressed
Propranolol Hcl	Propranolol Hcl	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Atenolol	Atenolol	29	suppressed
Eszopiclone	Eszopiclone	28	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Fluconazole	Fluconazole	26	13
Nebivolol Hcl	Nebivolol Hcl	26	suppressed
Mupirocin	Mupirocin	25	20
Nitrofurantoin	Nitrofurantoin Macrocrystal	25	suppressed
Metformin Hcl	Metformin Hcl	24	suppressed
Wegovy	Semaglutide	24	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Prednisone	Prednisone	23	suppressed
Sotalol	Sotalol Hcl	23	suppressed
Allopurinol	Allopurinol	22	suppressed
Anastrozole	Anastrozole	22	suppressed
Ibuprofen	Ibuprofen	22	suppressed
Praluent Pen	Alirocumab	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Terazosin Hcl	Terazosin Hcl	21	suppressed
Trazodone Hcl	Trazodone Hcl	21	suppressed
Duloxetine Hcl	Duloxetine Hcl	20	suppressed
Xarelto	Rivaroxaban	20	suppressed
Cephalexin	Cephalexin	19	16
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	19	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Hydrocortisone	Hydrocortisone	19	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Repatha Pushtronex	Evolocumab	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Jardiance	Empagliflozin	18	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	18	15
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Enalapril Maleate	Enalapril Maleate	16	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	15	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Ramipril	Ramipril	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Minivelle	Estradiol	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Dutasteride	Dutasteride	11	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Indapamide	Indapamide	11	suppressed
Minoxidil	Minoxidil	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Raloxifene Hcl	Raloxifene Hcl	11	suppressed
Tramadol Hcl Er	Tramadol Hcl	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error